GB00BN7SWP63
GB00BN7SWP63
GSK PLC ORD 31 1/4P
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 70.12B EUR | 7.94T EUR | 8.3T EUR | 7.32T EUR |
Enterprise Value | 84.84B EUR | 7.95T EUR | 8.31T EUR | 7.34T EUR |
Valuation Multiples | ||||
Trailing P/E | 14.83x | 1,646.52x | 1,423.54x | 1,789.08x |
Forward P/E | 9.19x | -- | -- | -- |
Price to Sales | 2.11x | 239.07x | 253.14x | 291.08x |
Price to Book | 397.37x | 449.86x | 464.81x | 447.02x |
EV/Revenue | 2.56x | 239.53x | 253.61x | 291.66x |
EV/EBITDA | 7.84x | 788.6x | 792.59x | 950.81x |
Price to FCF (P/FCF) | 20.14x | 1,489x | 1,744.34x | 1,803.62x |
EV/FCF | 24.36x | 1,491.84x | 1,747.62x | 1,807.21x |
FCF Yield | 4.97% | 0.07% | 0.06% | 0.06% |